Guangzhou Shiyun Biotech Interested in Cooperation with Ukraine
The HMECC Ukraine office has initiated cooperation with Guangzhou Shiyun Biotechnology Co., Ltd., a leading Chinese biotech company.
Shiyun Biotech is the developer of a groundbreaking technology – next-generation molecular fluorescent imaging agents (GGA-sNIR) – designed for intraoperative navigation and early cancer diagnostics. The company’s technology enables surgeons to accurately detect tumor margins and micro-metastases, significantly improving surgical outcomes and reducing the risk of recurrence.
Shiyun Biotech’s products are aimed at the treatment of seven major solid tumors (lung, prostate, bladder, kidney, colorectal, breast, and pancreatic cancers) and have already been recognized as a disruptive innovation at the global level.
The company has expressed a strong interest in cooperation with Ukrainian medical institutions, research centers, and government bodies to jointly advance projects in cancer diagnostics and treatment in Ukraine.
HMECC Ukraine is coordinating communication and invites potential partners to join the dialogue in order to bring cutting-edge technologies into clinical practice and create new opportunities for patients.
📩 For cooperation inquiries: info@hmecc.org.ua
